Skip to content
TrustList
RBV Capital logo
Venture capital firm

RBV Capital

Life sciences venture fund investing in early-stage biomedical projects around the world

  • external
  • Management
  • Science
  • Medical
  • +1 more
RBV Capital cover

About RBV Capital

RBV Capital is a venture capital fund dedicated to life sciences, set up in 2014. It puts money into early-stage biomedical projects across the globe and aims to build a spread of breakthrough assets.

What RBV Capital offers

  • Early-stage venture funding: backs young companies working on new science aimed at serious unmet medical needs.
  • Management selection: looks for strong teams with a clear vision before it invests.
  • Biopharmaceuticals: one of the fields it is interested in.
  • Biomedical technology and services: covers tools and services for medicine.
  • Bioinformatics and healthcare IT: software and data work in healthcare.
  • Medical devices: companies making devices for clinical use.

Clients

The fund works with early-stage life sciences companies worldwide. Its site separates current investments, exited investments and the wider portfolio.

Key facts

  • Founded: 2014
  • Focus: life sciences venture capital
  • Stage: early-stage companies
  • Reach: global

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

  • external
  • Management
  • Science
  • Medical
  • Early Stage

What the business tells TrustList

Founded
2014 (12 years) evidence sent

Ask TrustList to introduce you to RBV Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of RBV Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about RBV Capital.

RBV Capital alternatives

Similar listings buyers compare against this one.

Early-stage venture fund taking science and engineering research from labs to market

Investment manager backing early-stage cannabis and other emerging-industry companies for institutional investors

Oslo-based private investment company backing early and later-stage life science businesses

Life science investor putting money into young oncology and genetic disease drug developers